"The purpose of pursuing this listing has been predicated on the last three months of advanced discussions with two Fortune 500 Companies, as well as, North American, European and Australian-based investors, and a global medical devices distribution company... would afford greater profile and liquidity as well as ease of transaction facilitation and financial confidence given the significant growth program the business is executing across America."
"Importantly, there is significant and growing interest in the Company?s products and activities overseas and given that the US market now represents over 40% of the world?s devices markets and is home to many of the largest global respiratory companies, it is very important for KarmelSonix to start to develop a higher profile with potential investors and partners in this market."
Might bring out the eggs ;-)
KSX Price at posting:
2.2¢ Sentiment: Buy Disclosure: Held